Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Preferred Stock Liabilities: 2015

Historic Preferred Stock Liabilities for Editas Medicine (EDIT) over the last 1 years, with Dec 2015 value amounting to $119.8 million.

  • Editas Medicine's Preferred Stock Liabilities was N/A to $119.8 million in Q4 2015 from the same period last year, while for Dec 2015 it was $119.8 million, marking a year-over-year change of. This contributed to the annual value of $119.8 million for FY2015, which is N/A change from last year.
  • Editas Medicine's Preferred Stock Liabilities amounted to $119.8 million in FY2015.
  • In the past 5 years, Editas Medicine's Preferred Stock Liabilities ranged from a high of $119.8 million in FY2015 and a low of $119.8 million during FY2015.
  • Over the past 1 years, Editas Medicine's median Preferred Stock Liabilities value was $119.8 million (recorded in 2015), while the average stood at $119.8 million.